Stocks and InvestingStocks and Investing
Thu, January 21, 2021
Wed, January 20, 2021
Tue, January 19, 2021
Mon, January 18, 2021
Fri, January 15, 2021

Mayank Mamtani Downgraded (ARCT) to Hold and Decreased Target to $77 on, Jan 15th, 2021


Published on 2024-10-27 15:14:44 - WOPRAI, Mayank Mamtani
  Print publication without navigation


Mayank Mamtani of B. Riley Securities, Downgraded "Arcturus Therapeutics Holdings Inc." (ARCT) to Hold and Decreased Target from $138 to $77 on, Jan 15th, 2021.

Mayank has made no other calls on ARCT in the last 4 months.



There are 6 other peers that have a rating on ARCT. Out of the 6 peers that are also analyzing ARCT, 3 agree with Mayank's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Madhu Kumar of "Baird" Downgraded from Buy to Hold and Decreased Target to $69 on, Tuesday, December 29th, 2020
  • Steven Seedhouse of "Raymond James" Downgraded from Buy to Hold on, Tuesday, December 29th, 2020
  • Ed Arce of "HC Wainwright & Co." Downgraded from Strong Buy to Hold and Decreased Target to $50 on, Tuesday, December 29th, 2020


These are the ratings of the 3 analyists that currently disagree with Mayank


  • John Abbott of "Wells Fargo" Initiated at Buy on, Thursday, January 7th, 2021
  • Elemer Piros of "Roth Capital" Downgraded from Strong Buy to Strong Sell and Held Target at $77 on, Wednesday, December 23rd, 2020
  • Yigal Nochomovitz of "Citigroup" Initiated at Strong Buy and Held Target at $65 on, Tuesday, October 6th, 2020